This is associated with the fact that hyperexpression of HIF-2α, which develops under hypoxia, suppresses PPARa in the liver and, consequently, aggravates the course of NAFLD [273]. This evidence concerns the gene EPAS1 and metabolic dysfunction-associated steatotic liver disease.